Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Rainer Muche

Showing results (81-90 of 98) with videos related to

Pageof 10
Sort By:
The Journal of Clinical Endocrinology and Metabolism|February 15, 2007
Levothyroxine in euthyroid autoimmune thyroiditis and type 1 diabetes: a randomized, controlled trialBeate Karges, Rainer Muche, Ina Knerr, et al.
BMC Cancer|January 17, 2016
DocOx (AIO-PK0106): a phase II trial of docetaxel and oxaliplatin as a second line systemic therapy in patients with advanced pancreatic ductal adenocarcinomaThomas J Ettrich, Lukas Perkhofer, Goetz von Wichert, et al.
Blood|February 18, 2011
Radioimmunotherapy-based conditioning for hematopoietic cell transplantation in children with malignant and nonmalignant diseasesAnsgar S Schulz, Gerhard Glatting, Manfred Hoenig, et al.
BMC Public Health|March 8, 2012
Evaluation of a health promotion program in children: Study protocol and design of the cluster-randomized Baden-Württemberg primary school study [DRKS-ID: DRKS00000494]Jens Dreyhaupt, Benjamin Koch, Tamara Wirt, et al.
BMC Cancer|December 31, 2018
Neoadjuvant plus adjuvant or only adjuvant nab-paclitaxel plus gemcitabine for resectable pancreatic cancer - the NEONAX trial (AIO-PAK-0313), a prospective, randomized, controlled, phase II study of the AIO pancreatic cancer groupThomas J Ettrich, Andreas W Berger, Lukas Perkhofer, et al.
Trials|March 19, 2020
Implementation of the patient version of the evidence-based (S3) guideline for psychosocial interventions for patients with severe mental illness (IMPPETUS): study protocol for a cluster randomised controlled trialJohanna Breilmann, Reinhold Kilian, Steffi G Riedel-Heller, et al.
Alzheimer'S Research & Therapy|April 27, 2018
A language-based sum score for the course and therapeutic intervention in primary progressive aphasiaElisa Semler, Sarah Anderl-Straub, Ingo Uttner, et al.
Diagnostics (Basel, Switzerland)|July 10, 2020
Influence of Biopsy Technique on Molecular Genetic Tumor Characterization in Non-Small Cell Lung Cancer-The Prospective, Randomized, Single-Blinded, Multicenter PROFILER Study ProtocolMaik Haentschel, Michael Boeckeler, Irina Bonzheim, et al.
The American Journal of Gastroenterology|February 25, 2022
Green Tea Extract to Prevent Colorectal Adenomas, Results of a Randomized, Placebo-Controlled Clinical TrialThomas Seufferlein, Thomas J Ettrich, Stefan Menzler, et al.
Journal of Neurology, Neurosurgery, and Psychiatry|August 23, 2015
Neurofilaments in the diagnosis of motoneuron diseases: a prospective study on 455 patientsPetra Steinacker, Emily Feneberg, Jochen Weishaupt, et al.
Pageof 10

Showing results (81-90 of 98) with videos related to

Sort By:
Pageof 10
The Journal of Clinical Endocrinology and Metabolism|February 15, 2007
Levothyroxine in euthyroid autoimmune thyroiditis and type 1 diabetes: a randomized, controlled trialBeate Karges, Rainer Muche, Ina Knerr, et al.
BMC Cancer|January 17, 2016
DocOx (AIO-PK0106): a phase II trial of docetaxel and oxaliplatin as a second line systemic therapy in patients with advanced pancreatic ductal adenocarcinomaThomas J Ettrich, Lukas Perkhofer, Goetz von Wichert, et al.
Blood|February 18, 2011
Radioimmunotherapy-based conditioning for hematopoietic cell transplantation in children with malignant and nonmalignant diseasesAnsgar S Schulz, Gerhard Glatting, Manfred Hoenig, et al.
BMC Public Health|March 8, 2012
Evaluation of a health promotion program in children: Study protocol and design of the cluster-randomized Baden-Württemberg primary school study [DRKS-ID: DRKS00000494]Jens Dreyhaupt, Benjamin Koch, Tamara Wirt, et al.
BMC Cancer|December 31, 2018
Neoadjuvant plus adjuvant or only adjuvant nab-paclitaxel plus gemcitabine for resectable pancreatic cancer - the NEONAX trial (AIO-PAK-0313), a prospective, randomized, controlled, phase II study of the AIO pancreatic cancer groupThomas J Ettrich, Andreas W Berger, Lukas Perkhofer, et al.
Trials|March 19, 2020
Implementation of the patient version of the evidence-based (S3) guideline for psychosocial interventions for patients with severe mental illness (IMPPETUS): study protocol for a cluster randomised controlled trialJohanna Breilmann, Reinhold Kilian, Steffi G Riedel-Heller, et al.
Alzheimer'S Research & Therapy|April 27, 2018
A language-based sum score for the course and therapeutic intervention in primary progressive aphasiaElisa Semler, Sarah Anderl-Straub, Ingo Uttner, et al.
Diagnostics (Basel, Switzerland)|July 10, 2020
Influence of Biopsy Technique on Molecular Genetic Tumor Characterization in Non-Small Cell Lung Cancer-The Prospective, Randomized, Single-Blinded, Multicenter PROFILER Study ProtocolMaik Haentschel, Michael Boeckeler, Irina Bonzheim, et al.
The American Journal of Gastroenterology|February 25, 2022
Green Tea Extract to Prevent Colorectal Adenomas, Results of a Randomized, Placebo-Controlled Clinical TrialThomas Seufferlein, Thomas J Ettrich, Stefan Menzler, et al.
Journal of Neurology, Neurosurgery, and Psychiatry|August 23, 2015
Neurofilaments in the diagnosis of motoneuron diseases: a prospective study on 455 patientsPetra Steinacker, Emily Feneberg, Jochen Weishaupt, et al.
Pageof 10